Study reveals G6PD deficiency linked to higher ADHD risk and increased use of stimulant medications

 ADHD in the News 2023-12-07


In a recent study published in Nutrients, researchers investigated the risk of Attention Deficit/Hyperactivity Disorder (ADHD) among glucose 6-phosphate dehydrogenase (G6PD)-deficient individuals.

View Article: News-Medical.net, December 1, 2023




Other Articles in this Edition

Driven by Love: Mothers on a Mission Ensure the Neurodiverse Are Counted Among Christ’s Flock

Valuable Information on ADHD From the Scientific Community: Takeaways from the 2023 International Conference on ADHD

The Unmet Need for Mental Health Services is Even Worse for Children Who Are Racial and Ethnic Minorities

Lawsuits Seek to Link Tylenol Ingredient to Autism, ADHD

Study reveals G6PD deficiency linked to higher ADHD risk and increased use of stimulant medications

ADHD Medications for Children: What to Know

People with ADHD in the workplace may get ‘passed over for promotions’ and struggle to climb the corporate ladder, a clinical psychologist said

Virtual ADHD Care Provider Done Expands with 30 New Brick-and-Mortar Clinics

Can You Self-Diagnose ADHD?

Embracing an ADHD Identity: What can you learn from deaf people’s experiences?

How Undiagnosed ADHD Made Me Vulnerable To Predatory Grooming

Are You Anxious, Disorganized, and Forgetful? It Could Be ADHD